Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
(Q28370451)
scientific article
scientific article
Language:
Current Data About
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
| (P31) |
(Q13442814)
|
||||||||||||||||||||||
| (P304) |
708-15
|
||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||
| (P433) |
4
|
||||||||||||||||||||||
| (P478) |
18
|
||||||||||||||||||||||
| (P577) |
+2000-02-00T00:00:00Z
|
||||||||||||||||||||||
| (P921) |
(Q42824440)
(Q203174) (Q181600)
(Q574834)
|
||||||||||||||||||||||
| (P1433) |
(Q400292)
|
||||||||||||||||||||||
| (P1476) |
"Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas" (language: en)
|
||||||||||||||||||||||
| (P2093) |
H A Fine
W D Figg
K Jaeckle
P Y Wen
A P Kyritsis
J S Loeffler
V A Levin
P M Black
R Kaplan
J M Pluda
W K Yung
|